Gonadorelin
Research use only.
Gonadorelin
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH), a naturally occurring hypothalamic peptide responsible for regulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In research settings, Gonadorelin is widely studied for its role in reproductive endocrinology, hormonal regulation, and hypothalamic-pituitary-gonadal (HPG) axis function.
Product Overview
Gonadorelin is a research-grade decapeptide designed to mimic endogenous GnRH activity by stimulating the anterior pituitary to release LH and FSH. Preclinical and clinical research has established its importance in investigating reproductive hormone signaling, fertility mechanisms, testosterone regulation, and endocrine feedback pathways. Its well-characterized biological activity makes Gonadorelin a valuable tool for studies involving hormonal physiology and HPG axis function.
Key Research Features
HPG Axis and Hormonal Regulation Research
Gonadorelin is extensively studied for its ability to stimulate the release of LH and FSH, supporting research into the regulation of reproductive hormone signaling.
Testosterone and Fertility Pathways
Research has demonstrated Gonadorelin's role in investigating endogenous testosterone production, spermatogenesis, ovarian function, and fertility-related endocrine mechanisms.
Pituitary Function Research
Studies utilize Gonadorelin to evaluate anterior pituitary responsiveness and investigate disorders involving hypothalamic and pituitary hormone regulation.
Endocrine Feedback Mechanisms
Research continues to explore Gonadorelin's role in understanding the complex feedback systems that regulate reproductive hormones and maintain endocrine homeostasis.
Gonadorelin – Suggested Use (Research Context)
Typical Dose: 100–200 mcg per administration
Route: Subcutaneous or intramuscular injection
Frequency: 1–2 times daily (research protocol dependent)
Duration: As directed by a qualified professional.